Waverly Advisors, LLC
Source: SEC Form 13F · as of Mar 2026Waverly Advisors, LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $16.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$16.6M
BioSniper AIPage evidence connected
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 33,822 | $4.7M |
| REGNREGENERON PHARMACEUTICALS, INC. | 5,895 | $4.6M |
| SYRESpyre Therapeutics, Inc. | 25,966 | $1.3M |
| VKTXViking Therapeutics, Inc. | 38,218 | $1.2M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 19,730 | $1.1M |
| INCYIncyte Corp. | 8,242 | $776K |
| EXELEXELIXIS, INC. | 12,665 | $543K |
| SNYSanofi | 10,640 | $513K |
| BMRNBIOMARIN PHARMACEUTICAL INC | 6,676 | $377K |
| TEVATeva Pharmaceutical Industries Limited | 11,896 | $358K |
| ROIVRoivant Sciences Ltd. | 12,578 | $348K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 907 | $300K |
| IBRXImmunityBio, Inc. | 27,558 | $211K |
| SERSerina Therapeutics, Inc. | 67,492 | $131K |
| OPKOPKO HEALTH, INC. | 32,556 | $37K |
| AUTLAutolus Therapeutics plc | 26,870 | $37K |
| HUMAHumacyte Inc. | 22,826 | $14K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.